StockData
FitLife Brands, Inc. logo

FitLife Brands, Inc. (FTLF) stock

FTLFNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/3019% above fair value
$8.48+0.18 (+2.17%)

Close on Nov 13, 2026Market cap $79.64MP/E 44.6Yield –

Earnings

FitLife Brands's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 12, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
$26.50M
+64.6% on a year earlier
EPS, Q2 FY2026
$0.20
$0.18 a year earlier
Latest guidance
Issued
Mar 27, 2025 · 1 item

Quarterly results

Revenue and earnings per share from each of FitLife Brands's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 12, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 13, 2026before the open$26.50M+64.6%$0.20Release
Q1 FY2026ended Mar 31, 2026May 14, 2026during market hours$25.30M–$0.17Release
Q4 FY2025ended Dec 31, 2025Apr 1, 2026before the open$25.90M+72.7%$0.16Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025before the open$23.50M+46.9%$0.09Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025before the open$16.10M-4.7%$0.18Release
Q4 FY2024ended Dec 31, 2024Mar 27, 2025during market hours$15.00M–$0.21Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024before the open$16.00M+15.1%$0.43Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024during market hours$16.90M+14.2%$0.53Release
Q1 FY2024ended Mar 31, 2024May 14, 2024before the open$16.50M–$0.43Release
Q4 FY2023ended Dec 31, 2023Mar 15, 2024before the open–––Release
Q3 FY2023ended Sep 30, 2023Nov 14, 2023before the open$13.90M–$0.35Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period FitLife Brands guided for has been reported

Guidance vs results

The last range FitLife Brands gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q1 FY2024Revenue$16.00M – $17.00M$16.50MWithin range

Guidance history

Every forecast FitLife Brands put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Mar 27, 2025revenue declineQ1 FY2025-6% – -4%New
Mar 13, 2025Adjusted EBITDAFY2024$14.00M – $14.20MNew
Mar 13, 2025Net incomeFY2024$8.90M – $9.10MNew
Mar 13, 2025Net revenueFY2024$64.00M – $65.00MNew
May 8, 2024Adjusted EBITDAQ1 FY2024$3.50M – $3.70MNew
May 8, 2024Net revenueQ1 FY2024$16.00M – $17.00MNew
Mar 15, 2024Adjusted EBITDAFY2023$10.00M – $10.50MNew
Mar 15, 2024Net revenueFY2023$52.00M – $53.00MNew
Nov 14, 2023online revenue from MusclePharm productsFY2024$5.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases FitLife Brands filed with the SEC as exhibits to Form 8-K or 6-K

  1. 8-K exhibit EX-99.1
    Update
  2. FitLife Brands Announces Second Quarter 2026 Results
    Results
  3. FitLife Brands Announces First Quarter 2026 Results
    Results
  4. 8-K exhibit EX-99.1
    Update
  5. FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results
    Results
  6. 8-K exhibit EX-99.1
    Update
  7. FitLife Brands Announces Third Quarter 2025 Results
    Results
  8. 8-K exhibit EX-99.1
    Update
  9. FitLife Brands Announces Second Quarter 2025 Results
    Results
  10. FitLife Brands Closes Acquisition of Irwin Naturals
    News
  11. FitLife Brands to Acquire Irwin Naturals
    Update
  12. FitLife Brands Announces First Quarter 2025 Results
    Results
  13. FitLife Brands Announces Board Transition
    News
  14. 8-K exhibit EX-99.1
    Update
  15. FitLife Brands Announces Fourth Quarter and Full-Year 2024 Results
    Results

See a number that looks wrong?